Sugi Predict

Sugi Predict / Compounds / SCHEMBL10115817

SCHEMBL10115817

SCHEMBL10115817

Cc1cc(-c2ncco2)ccc1NC(=O)N1CCC(NS(=O)(=O)C(C)(C)C)CC1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.39
▸ FAAH O00519 1/20 0.39
▸ EPHX2 P34913 1/20 0.39
▸ THRB P10828 1/20 0.38
▸ CCR8 P51685 6/20 0.38
▸ KIF18A Q8NI77 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ KMT2A Q03164 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ LTA4H P09960 1/20 0.36
▸ NPY5R Q15761 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10116153 0.88 GRIA2 (0.39) RAB9AFAAHEPHX2THRBCCR8
SCHEMBL10115832 0.87 FAAH (0.36) RAB9AFAAHEPHX2THRBKIF18A
SCHEMBL10115780 0.86 FAAH (0.49) FAAHEPHX2CCR8KIF18ALTA4H
SCHEMBL10115831 0.79 HDAC1 (0.52) RAB9ATHRBCCR8NPC1MAPK1
SCHEMBL10115667 0.78 NPY5R (0.48) RAB9AEPHX2THRBCCR8NPC1
SCHEMBL10115712 0.77 HRH3 (0.45) RAB9ATHRBCCR8NPC1KMT2A
SCHEMBL10116160 0.77 GSK3B (0.36) RAB9AFAAHEPHX2THRBNPC1
SCHEMBL10115561 0.76 HRH3 (0.47) RAB9ATHRBCCR8NPC1MAPK1
SCHEMBL10133585 0.76 HRH3 (0.47) RAB9ATHRBCCR8NPC1MAPK1
SCHEMBL10115807 0.75 THRB (0.44) RAB9ATHRBCCR8NPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R RAB9A 3699/4885FAAH 974/4885EPHX2 2158/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R RAB9A 3651/4885FAAH 994/4885EPHX2 2527/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R RAB9A 3820/4885FAAH 974/4885EPHX2 2306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.